Literature DB >> 8296613

ANCA in systemic vasculitides, collagen vascular diseases, rheumatic disorders and inflammatory bowel diseases.

S Hauschild1, W H Schmitt, E Csernok, B K Flesch, A Rautmann, W L Gross.   

Abstract

It was the aim of this study to reevaluate the diagnostic significance and clinical implication of ANCA after testing sera from 13,606 patients for the presence of ANCA. Our data confirm the high specificity (97%) and sensitivity (80%) of cANCA for Wegener's granulomatosis. pANCA were found in renal vasculitides (60%), collagen vascular diseases (SLE 20%, Sjögren's syndrome 26%, polymyositis 16%) and rheumatic disorders (Felty's syndrome 50%, rheumatoid arthritis 20%). A third fluorescence pattern in sera of patients with inflammatory bowel disease (ulcerative colitis 28/72, Crohn's disease 6/84), here called xANCA, was seen. Target antigens of granule proteins from PMN and monocytes (proteinase 3, myeloperoxidase, elastase, cathepsin G, lactoferrin, lysozyme) were identified.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8296613     DOI: 10.1007/978-1-4757-9182-2_36

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  12 in total

Review 1.  Clinical utility of testing for antineutrophil cytoplasmic antibodies.

Authors:  D Vassilopoulos; G S Hoffman
Journal:  Clin Diagn Lab Immunol       Date:  1999-09

Review 2.  Rare diseases.3: Wegener's granulomatosis.

Authors:  C A Langford; G S Hoffman
Journal:  Thorax       Date:  1999-07       Impact factor: 9.139

Review 3.  ANCA testing. New developments and clinical implications.

Authors:  A E Ahmed; J B Peter; Y Y Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

Review 4.  Pharmacological therapy for Wegener's granulomatosis.

Authors:  Eric S White; Joseph P Lynch
Journal:  Drugs       Date:  2006       Impact factor: 9.546

5.  Autoantibodies and target antigens in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides.

Authors:  J A Savige; L Chang; D Wilson; R R Buchanan
Journal:  Rheumatol Int       Date:  1996       Impact factor: 2.631

Review 6.  Adult-onset Henoch-Schonlein purpura with positive c-ANCA (anti-proteinase 3): case report and review of literature.

Authors:  Eman Boulis; Vikas Majithia; Robert McMurray
Journal:  Rheumatol Int       Date:  2010-10-21       Impact factor: 2.631

7.  Autoantibodies to early endosome antigen (EEA1) produce a staining pattern resembling cytoplasmic anti-neutrophil cytoplasmic antibodies (C-ANCA).

Authors:  S Selak; R C Woodman; M J Fritzler
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

8.  Clinical features and outcomes of microscopic polyangiitis in Korea.

Authors:  Ji Seon Oh; Chang-Keun Lee; Yong Gil Kim; Seong-Su Nah; Hee-Bom Moon; Bin Yoo
Journal:  J Korean Med Sci       Date:  2009-04-20       Impact factor: 2.153

Review 9.  Killing three birds with one BPI: Bactericidal, opsonic, and anti-inflammatory functions.

Authors:  Jomkuan Theprungsirikul; Sladjana Skopelja-Gardner; William F C Rigby
Journal:  J Transl Autoimmun       Date:  2021-05-28

10.  Differential Enhancement of Neutrophil Phagocytosis by Anti-Bactericidal/Permeability-Increasing Protein Antibodies.

Authors:  Jomkuan Theprungsirikul; Sladjana Skopelja-Gardner; Rachel M Wierzbicki; Katherine J Sessions; William F C Rigby
Journal:  J Immunol       Date:  2021-07-16       Impact factor: 5.426

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.